LT252 Respiratory Multiplex Array - 8 Pages

  1. P. 1

  2. P. 2

  3. P. 3

  4. P. 4

  5. P. 5

  6. P. 6

  7. P. 7

  8. P. 8

Catalogue excerpts

Respiratory Multiplex Array Rapid, simultaneous detection of 22 bacterial and viral pathogens - of the upper and lower respiratory tract

 Open the catalogue to page 1

Respiratory Multiplex Array Rapid, simultaneous detection of 22 bacterial and viral pathogens within the upper and lower respiratory tracts Introduction Respiratory tract infections are caused by many viral and bacterial pathogens and are the second most common cause of morbidity and mortality worldwide.1 Acute respiratory disease (ARD) accounts for more than 4 million deaths annually and are the leading cause of death in developing countries.2 Viral respiratory infections can occur in epidemics and can spread rapidly within communities across the globe. Every year, influenza causes respiratory...

 Open the catalogue to page 2

The Respiratory Multiplex Array is the most comprehensive screening test for infections of both the upper and lower respiratory tracts, simultaneously detecting 22 bacterial and viral pathogens from a single sputum, lavage or nasopharyngeal sample. The assay is based on a combination of multiplex PCR and biochip array hybridisation. Innovative PCR priming technology permits high discrimination between multiple targets. A unique primer set is designed for each target which will hybridise to a complementary oligo-nucleotide probe spotted on a biochip discrete test region (DTR). This combination...

 Open the catalogue to page 3

Evidence Investigator - rapid, accurate and comprehensive molecular testing The Evidence Investigator is a compact, semi-automated bench top platform consolidating immunoassay and molecular diagnostics on a single platform with protein and DNA biochips. Utilising revolutionary Biochip Array Technology (BAT), the Evidence Investigator allows simultaneous detection of multiple analytes from a single sample for efficient and cost-effective testing. The Evidence Investigator offers complete patient profiling with the most comprehensive test menu on the market Benefits of the Randox Respiratory Multiplex...

 Open the catalogue to page 4

Mass gatherings, such as the Hajj increase the likelihood of the spread of infectious diseases. The Kingdom of Saudi Arabia annually hosts over 2 million Muslim pilgrims from around 184 countries during the Hajj pilgrimage, making it one of the largest and most culturally and geographically diverse mass gatherings in the world. Respiratory tract infections (RTIs) are the most common infection transmitted between pilgrims during Hajj, and most pilgrims develop RTIs during their few weeks stay in Makkah and Madinah. The Randox Respiratory Multiplex Array was used to screen for the presence of bacterial...

 Open the catalogue to page 5

References Respiratory Multiplex Array 1. umla, A. et al. Emerging respiratory tract infections 4 Rapid point of care diagnostic tests for viral and bacterial Z respiratory tract infections – needs, advances, and future prospects. Lancet Infect Dis 2014. Available online: http:// www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(14)70827-8.pdf. Last accessed 12 January 2015. 2. orum of International Respiratory Societies. Respiratory Diseases in the World. Realities of Today – Opportunities F for Tomorrow. Available online: http://www.thoracic.org/global-health/firs-report-respiratory-diseases-in-the-world/...

 Open the catalogue to page 6

SINCE THEIR DISCOVERY LAST CENTURY, ANTIBIOTICS HAVE severe infections surgical procedures IN RECENT YEARS, SOME PATHOGENS HAVE ACQUIRED RESISTANCE RENDERING THEM INEFFECTIVE Tract Infections) Staphylococcus Streptococcus aureus pneumoniae Patient misuse • Asking GPs to prescribe antibiotics • Obtaining antibiotics without a • Saving antibiotics for future use • Sharing antibiotics with other • Unnecessarily repeating courses of Inappropriate prescribing Antibiotics are ineffective against many RTIs, particularly viral WHAT CAN BE DONE TO PREVENT ANTIMICROBIAL RESISTANCE? RESIST ASKING DESIST...

 Open the catalogue to page 7

PRECISE DIAGNOSTICS FOR TARGETED THERAPY Understanding drivers of disease is vital in delivering effective patient care. Through the unravelling of the genetic code, healthcare practitioners are able to predict and prevent disease and prescribe appropriate targeted treatments to specific subgroups, for optimal patient outcomes. Randox Laboratories Limited, 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom T +44 (0) 28 9442 2413 F +44 (0) 28 9445 2912 E marketing@randox.com I www.randoxbiosciences.com *Products may be for Research Use Only and not for use in diagnostic procedures...

 Open the catalogue to page 8

All Randox Laboratories catalogues and technical brochures

  1. Preparing QC

    1 Pages

    En
  2. Acusera 24•7

    28 Pages

    En
  3. RX modena

    22 Pages

    En
  4. RX Series

    13 Pages

    En
  5. Linearity sets

    16 Pages

    En
  6. 2017 Product List

    92 Pages

    En
  7. Evidence

    16 Pages

    En
  8. Acusera

    132 Pages

    En
  9. Evidence Evolution

    16 Pages

    En
  10. RX Monaco

    16 Pages

    En
  11. Rx Imola

    16 Pages

    En
  12. RX Daytona Plus

    16 Pages

    En
  13. Rx Monza

    16 Pages

    En
  14. Carbon Dioxide

    2 Pages

    En
  15. Thyroid Arrays

    4 Pages

    En
  16. Cerebral Arrays

    4 Pages

    En
  17. Endocrine Array

    4 Pages

    En
  18. Rx Daytona

    16 Pages

    En

Archived catalogues

  1. RIQAS Explained

    36 Pages

    En
  2. Molecular Testing

    16 Pages

    En
  3. Fertility Array

    4 Pages

    En
  4. Evidence

    16 Pages

    En